ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesImmune targeting of cancer stem cells in gastrointestinal oncologyCancer Stem Cell Plasticity Drives Therapeutic ResistanceAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsOvarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolismDoxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem CellsIdentification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancerCT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancerTranscription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype.Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like populationAldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcomaThe Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structureThe metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeTargeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxiaModeling of Patient-Derived Xenografts in Colorectal Cancer.ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.Influence of nuclear structure on the formation of radiation-induced lethal lesions.Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Biliary tract cancer stem cells - translational options and challenges.Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.Barriers to generating PDX models of HPV-related head and neck cancer.Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.Distinct prognostic values of ALDH1 isoenzymes in breast cancer.Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway.Salinomycin kills cancer stem cells by sequestering iron in lysosomes.Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation.
P2860
Q26747144-560E31CE-D98C-468A-9E7B-950C9E2DE664Q26749015-02BC8A01-AEB0-45D4-89C1-E3EFE535FC15Q26770274-1C008847-5EEB-430A-A67E-4EAF7EC5053DQ26786476-4ABC4804-A2EA-4F5A-9A43-7FB99DCFE5B5Q27340125-0762ED5B-27B6-4533-8751-001B8BCD436CQ28538384-97C5EC39-A105-4D4A-A38B-6730773D9AA5Q28545782-15EE6762-79D3-4DF4-BD63-E4CD396228ACQ30277772-35FEDB36-3F20-4EF8-9D2A-CDE1BF815DA2Q30829189-509E186D-CC3C-4788-86B0-69884F3EFD2CQ33739585-8FE51DCC-A754-4068-A547-BA9EA4CC74E2Q33767021-A35584FF-70DB-4C81-A4D6-871057D90F05Q33857917-852001D8-6F19-4BF9-8271-EA6E44592B43Q33892734-96BFE4C5-15A6-460C-9D7C-0AFE17D1B3EFQ34170564-684B59F7-2F83-4EF9-8C22-F04B199EFCFAQ34354781-C8BFAF94-FA08-4ACD-93BF-1DDC99612E71Q34452128-DE6ABF3C-2921-4784-9DD3-0FCCC8D526A5Q36104984-AD50F2ED-651E-417D-A3AE-D7FA10078A41Q36414048-2725C916-7CCD-49A5-92C5-E0F354B31428Q36545318-DF6FDB8E-49A9-41C6-B4C6-72C9C2E9049DQ36562382-7C6AC0EF-C7A5-46E8-BE66-9CF48997FD57Q36660550-FA16F57A-5469-4E5C-AF0F-4F33494C38A1Q37694797-02DB17F4-EC10-498E-B105-358BC31049B2Q37736204-B7B84920-8F12-4509-9AB5-3CA0176D4311Q38591389-FD1BDA60-C676-428F-A1D9-660CB5C3A9DFQ38685879-C817BA63-1B63-4C5F-B975-9EB0BAE1EE24Q38705019-C7A62D9C-EBF1-4F6B-8CD4-F45AF4172F6EQ38743865-43601401-1024-410B-9F7C-4DC0A5331F15Q38751001-CF39BA96-C8C5-48FE-9594-03E518818082Q39037708-E09716D9-0265-4807-8935-C57F2EF9908AQ39057246-A7955530-54C9-475C-9C77-2FADE3C9577BQ39279276-7B9CF0CC-1061-4470-9176-C74ECE61730BQ39787293-065889DB-2546-4262-9F69-AA6DAF022826Q40179397-645BC3B0-815F-47D6-B6BB-5BB9C578099DQ40256299-8F8A181C-2DA7-47BD-B5AB-ACE715BEEC09Q41591538-976290AF-CCC2-4628-86CF-FE35DEBDDCA2Q41613353-400F10B3-88C9-4366-83A8-6C220F23201CQ46302821-0568267B-9879-410A-B1AA-40E6013C419EQ48121718-BF2D5B9B-4BFD-4D6C-ABB2-0453FA02F897Q48158656-57A92CA9-DDCB-422C-AB59-E360F2F5369AQ49423163-0C179A6F-59EA-4CD3-80B1-DEFB6DA852D5
P2860
ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@en
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@nl
type
label
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@en
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@nl
prefLabel
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@en
ALDH1-positive cancer stem cel ...... by a common stem cell program.
@nl
P2093
P50
P1433
P1476
ALDH1-positive cancer stem cel ...... by a common stem cell program
@en
P2093
Aurélie Jalaguier
Emmanuelle Josselin
Eric Lambaudie
Florence Monville
François Bertucci
Gilles Houvenaeghel
Jocelyne Jacquemier
José Adelaide
Julien Wicinski
P304
P356
10.1158/0008-5472.CAN-12-4704
P407
P50
P577
2013-10-18T00:00:00Z